Arrowhead Pharmaceuticals Inc (ARWR)
EBITDA Margin
-19.97%
TTM · Period ending:
ARWR EBITDA Margin
Latest reported-19.97%period ending
Latest reported-19.97%period ending
ARWR TTM EBITDA Margin (-100.00% → -19.97%)
TTM ebitda margin
High-resolution chart · PNG
ARWR ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -578.5177% | |
| -560.9063% | |
| -414.0286% | |
| -408.4452% | |
| -587.6636% | |
| 1,536.3309% | |
| 1,368.3878% | |
| 1,225% | |
| 1,375% | |
| -200% | |
| -100% |